Estudios: Contra ómicron se requieren refuerzos de vacuna [Los Angeles Times (CA)]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Los Angeles Times
Se trata de los primeros estudios de gran envergadura realizados en Estados Unidos que analizan la protección de la vacuna contra la variante ómicron, dijeron funcionarios de salud. Los documentos refrendan investigaciones anteriores —incluidos estudios en Alemania, Sudáfrica y Gran Bretaña— según las cuales las vacunas disponibles tienen una eficacia menor contra ómicron que contra las versiones previas del nuevo coronavirus, aunque también señalan que las dosis de refuerzo aceleran la producción de anticuerpos a fin de aumentar la posibilidad de evitar una infección sintomática. Salud Internacional Cuba: “Todos los niños y niñas a partir de dos años están ya vacunados” Hace 38 minutos California Oleada de COVID-19 deja a empresas de San Diego sin personal y con exceso de trabajo Hace 1 hora California Aumento de COVID-19 en LAPD y Departamento del Sheriff tiene a miles de empleados en casa Hace 1 hora Anuncio El primer estudio examinó las hospitalizaciones
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Inhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center Stage [Yahoo! Finance]Yahoo! Finance
- Obsessive-Compulsive Disorder (OCD) Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]Yahoo! Finance
- UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Reuters]Reuters
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website